BackArno Therapeutics Overview

Arno Therapeutics Total Liabilities

Latest total liabilities for ARNI: $8.1M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$8.07M
↑ 42.72% YoYΔ $2.42M vs prior year quarter

Peer trimmed avg / median

Loading

Arno Therapeutics Total Liabilities History

Loading

Arno Therapeutics vs. peers: Total Liabilities Comparison

Loading

Arno Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Arno Therapeutics (ARNI) FAQ

As of the most recent data (September 2016), ARNI shows a total liabilities of $8.1M. That compares with $5.7M in the prior-year period — up 42.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ARNI's total liabilities is now $8.1M (was $5.7M) — a 42.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Arno Therapeutics is outperforming or lagging.

Tracking ARNI's total liabilities over time shows whether Arno Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $8.1M That compares with $5.7M in the prior-year period — up 42.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Arno Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $8.1M) with ownership activity and broader fundamentals.

Arno Therapeutics's total liabilities is $8.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.